CEBRX | MEDEX | CEBRX / MEDEX | |
Total Expense Ratio | 0.75 | 1.31 | 57% |
Annual Report Gross Expense Ratio | 0.75 | 1.32 | 57% |
Fund Existence | 13 years | 17 years | - |
Gain YTD | 8.069 | 6.585 | 123% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 330M | 7.47B | 4% |
Annual Yield % from dividends | 5.37 | 4.77 | 113% |
Returns for 1 year | 7.96 | 6.99 | 114% |
Returns for 3 years | 28.30 | 27.45 | 103% |
Returns for 5 years | 10.58 | 8.16 | 130% |
Returns for 10 years | 48.81 | 39.81 | 123% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RRRAX | 21.79 | 0.12 | +0.55% |
DWS RREEF Real Estate Securities A | |||
TSPTX | 6.14 | -0.01 | -0.16% |
Transamerica Small Cap Growth I3 | |||
VEUSX | 98.11 | -0.52 | -0.53% |
Vanguard European Stock Admiral | |||
VDSIX | 24.74 | -0.22 | -0.88% |
Victory Diversified Stock I | |||
VMGRX | 29.02 | -0.33 | -1.12% |
Vanguard Mid Cap Growth Inv |